Bioray Biotech Co., Ltd (TPEX: 7561)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.30
0.00 (0.00%)
Dec 31, 2024, 2:21 PM CST

Bioray Biotech Revenue

Bioray Biotech had revenue of 85.80M TWD in the half year ending June 30, 2024, a decrease of -3.45%. This brings the company's revenue in the last twelve months to 183.57M, down -6.24% year-over-year. In the year 2023, Bioray Biotech had annual revenue of 191.83M with 0.65% growth.

Revenue (ttm)
183.57M
Revenue Growth
-6.24%
P/S Ratio
3.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
662.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023191.83M1.23M0.65%
Dec 31, 2022190.60M42.58M28.77%
Dec 31, 2021148.02M-8.28M-5.30%
Dec 31, 2020156.30M-25.64M-14.09%
Dec 31, 2019181.93M-3.56M-1.92%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PharmaEssentia 8.32B
Lotus Pharmaceutical 17.59B
Oneness Biotech 112.20M
Lumosa Therapeutics 37.82M
Polaris Group 75.65M
Center Laboratories 1.57B
Pegavision 7.06B
TaiMed Biologics 622.61M
Revenue Rankings